EVT 201

Evotec Neurosciences GmbH · Phase 2 active Small molecule

At a glance

Generic name	EVT 201
Sponsor	Evotec Neurosciences GmbH
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy Study of EVT 201 to Treat Insomnia (PHASE2)
Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EVT 201 CI brief — competitive landscape report
EVT 201 updates RSS · CI watch RSS
Evotec Neurosciences GmbH portfolio CI